Hip Replacement Implants Market Size, Share & Trends Analysis Report By Procedure (Total Hip Replacement Implants, Partial Femoral Head, Hip Resurfacing, Revision Hip), By Material (Metal on metal, Metal on polyethylene, Ceramic on metal, Ceramic on polyethylene, Ceramic on ceramic), By End User (Hospitals & Surgery Centers, Orthopedic Clinics, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Hip Replacement Implants Market Size & Growth Analysis

The global hip replacement implants market size was valued at USD 4.37 billion in 2025 and is projected to grow from USD 4.47 billion in 2026 to USD 5.39 billion by 2034, registering a CAGR of 2.35% during the forecast period from 2026 to 2034. North America dominated the hip replacement implants market with a market share of 52.16% in 2025.

Key Market Trends & Insights

• North America held a dominant share of the global market, accounting for 52.16% share in 2025, due to the high prevalence of osteoarthritis, advanced surgical technologies, and increasing adoption of elective hip replacement procedures.
• The Asia Pacific region is growing at the fastest pace, with a CAGR of 4.35 %, due to several factors, such as a rising geriatric population, expanding access to advanced orthopaedic procedures, and growing adoption of innovative implant technologies.
• Based on the procedure, the total hip replacement implants held the highest market share of 39.60%in 2025, attributed to various reasons, such as rising prevalence of osteoarthritis and advancements in implant technology.
• Based on material, the ceramic on polyethylene segment is expected to register the fastest CAGR growth of 3.32%. The growth is attributed to its superior wear resistance, lower risk of implant loosening, longer durability, and improved patient outcomes.
• Based on end user, the hospitals & surgery centers segment dominated the market in 2025. The growth is attributed to high patient inflow, availability of advanced surgical facilities, and presence of skilled orthopedic surgeons.
• The U.S. dominates the global hip replacement implants market, valued at USD 2.08 billion in 2024 and reaching USD 2.12 billion in 2025.

Market Size and Forecast

• 2025 Market Size: USD 4.37 billion
• 2034 Projected Market Size: USD 5.36 billion
• CAGR (2025 to 2034): 2.35%
• Dominating Region: North America
• Fastest-Growing Region: Asia Pacific

Market Drivers

Increasing Hip Replacement Procedures

The rising number of hip replacement procedures per 100,000 population is a key driver for the growth of the market.

Such factor reflects the growing prevalence of surgeries for the hip replacement, which fuels demand for advanced implants.

Adoption of Bundled Payment Reimbursement Models

The rise of bundled payment reimbursement models is driving the growth of the market by promoting cost-efficient, and high-quality care.

• For example, as per the Commonwealth Fund, Centers for Medicare & Medicaid Services, programs such as Comprehensive Care for Joint Replacement (CJR) Model, Bundled Payment for Care Improvement (BPCI) and long-term care bundled payments in U.S. and England, incentivize hospitals and providers to optimize surgical outcomes and post-operative recovery.

Such factor links financial accountability to patient outcomes across the entire care continuum, while encouraging the use of advanced, as well as durable hip implants.

Market Restraint

Product Recalls Impacting Hip Replacement Implants

Product recalls have impacted the market, leading to potential delays in surgeries and increased healthcare costs.

• For instance, in July 2024, as per U.S. FDA,Stryker's UNITRAX Endoprosthesis Head Component was recalled due to potential issues and Zimmer Biomet's M/L Taper Hip Prosthesis with Kinectiv Technology was recalled due to the presence of black residue within the packaging, which caused surgical delays as well as necessitate additional interventions.

Such factors highlight the critical importance of stringent quality control and regulatory compliance, as these lapses directly affect patient safety, surgical outcomes, and trust in healthcare providers, while also posing operational and financial challenges for manufacturers.

Market Opportunity

Personalized Hip Replacement Implants

The development and adoption of personalized hip replacement implants presents as a significant market opportunity as it enables the creation of implants tailored to an individual’s unique anatomy.

• For example, in February 2024, the ReNew Hip implant by CytexOrtho, received FDA Breakthrough Device designation, as it integrates a 3D-woven textile and a high-precision Tru3D printed component to form an implant that recreates the form and contour of a healthy articular joint surface while mimicking the function of articular cartilage and bone. This approach allows for the removal of only the damaged tissue, preserving healthy bone and cartilage.

Such a factor allows manufacturers to cater the specific needs of patients, leading to improved surgical outcomes and patient satisfaction, thereby capitalizing on this emerging market opportunity.

Market Segmentation

Procedure Insights

The total hip replacement implants segment dominated the market with a revenue share of 39.60% in 2025. The growth is attributed to rising osteoarthritis prevalence, advanced implant designs, and minimally invasive surgical adoption.

Request Customizationto receive a tailored report.

Material Insights

The ceramic on polyethylene segment is anticipated to grow at a CAGR of 3.32% during 2026 - 2034. This growth is attributed to the longer implant lifespan and reduced risk of osteolysis.

End-User Insights

The hospitals & surgery centers segment dominated the market in 2025. This growth is attributed to the availability of advanced surgical infrastructure, skilled orthopedic specialists, and higher patient inflow.

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America Market Trends

The North America region dominated the market with a revenue share of 52.16% in 2025. The growth is attributed to factors such as high prevalence of osteoarthritis and hip fractures, advanced healthcare infrastructure, widespread adoption of technologically advanced implants and robotic-assisted surgeries.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Market Growth Factors

The Asia Pacific region is the fastest-growing region with a CAGR of 4.35% during the forecast timeframe. The growth is attributed to factors such as a growing aging population, rising government initiatives to improve healthcare access and the expansion of leading global implant manufacturers establishing a stronger presence across the region.

Countries Analysis

• U.S.: The market in U.S. is widely driven by the widespread adoption of robotic-assisted surgeries that optimize implant placement and the presence of major market players manufacturing advanced implant devices that enhance surgical outcomes and patient recovery times, which further contribute to the market's expansion. For example, in March 2025, Stryker’s Mako SmartRobotics system, used in over 500,000 U.S. procedures, enables precise positioning of hip implants, improving alignment, reducing complications, and enhancing patient recovery.
• UK: The market in UK is propelling due to the high prevalence of osteoarthritis and hip fractures, which increases the demand for surgical interventions as well as adoption of advanced implant designs and durable materials.
• Germany: In Germany, the market is driven by high surgeon expertise and an increase in number of hip replacement operations every year, which fuels the growth of the market.
• China: The hip replacement implants market in China is fuelled by the increasing cases of trauma, sports injuries and aging population. For example, in February 2024, according to an article published in the International Journal of Physical Activity and Health, the incidence of sports injury among Chinese college rock climbers was high with 87.0%, indicates a growing risk of joint damage, including the hips. Such injuries can accelerate cartilage wear or lead to fractures, increasing the future demand for hip replacement implants.
• India: India continues to position itself in the hip replacement implants market, due to advancements in implant technology and research collaborations. For instance, in January 2025, IIT Guwahati partnered with Miraclus Orthotech to promote the research, development, and testing of advanced orthopedic implants and instruments, enhancing implant quality, surgical outcomes, and adoption of innovative hip replacement solutions in India.

Competitive Landscape

The global hip replacement implants market is highly fragmented in nature due to the presence of numerous manufacturers competing across regions, ranging from large multinational companies to smaller local players. This fragmentation is driven by diverse product offerings, varying implant technologies (such as ceramic on polyethylene, metal on polyethylene, and 3D printed implants), as well as the need to cater to specific patient demographics and surgical preferences.

The industry participants are inclined towards innovation in implant materials and designs, adoption of robotic-assisted and minimally invasive surgical technologies, strategic collaborations with research institutions, and expansion into emerging markets to enhance patient outcomes.

Matortho Limited: An Emerging Market Player

MatOrtho Limited is an emerging player in the market, is an orthopaedic medical device manufacturer that specializes in designing and producing advanced joint replacement devices.

• In December 2024, MatOrtho, a UK-based innovator in hip and knee replacement devices, announced that its ReCerf Hip Resurfacing Arthroplasty became the world’s first all-ceramic hip resurfacing system to receive regulatory approval.

List of Key and Emerging Players in Hip Replacement Implants Market

• MatOrtho Limited
• Smith+Nephew
• OMNIlife science, inc.
• MicroPort Scientific Corporation
• Exactech, Inc.
• Zimmer Biomet
• Medical Device Business Services, Inc
• Stryker
• Braun Melsungen AG
• Enovis Corporation
• Aesculap, Inc
• Greens Surgicals Pvt. Ltd.
• NRV OrthoTech Pvt Ltd
• HCM ORTHOCARE PVT.LTD
• Sharma Orthopedic